Literature DB >> 23331232

A Bayesian group sequential approach to safety signal detection.

Wenfeng Chen1, Naiqing Zhao, Guoyou Qin, Jie Chen.   

Abstract

Clinical safety data, usually reported as clinically manifested adverse events (AEs) according to the Medical Dictionary for Regulatory Activities (MedDRA), are routinely collected during the course of a clinical trial involving comparative groups, and periodical monitoring of the safety events is often required to determine whether excessive occurrence of a set of AEs is associated with treatment. To accommodate the structure of reported AEs with the MedDRA system, a Bayesian hierarchical model has been proposed for the analysis of clinical safety data. However, the characteristics of sequential use of the Bayesian method has not been studied. In this paper the Bayesian hierarchical model is applied in a group sequential manner for multiple interim analyses of safety events. A decision-theoretic approach is employed to determine threshold values in the safety signaling process. The proposed approach is illustrated through simulations and a real example.

Mesh:

Substances:

Year:  2013        PMID: 23331232     DOI: 10.1080/10543406.2013.736813

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  4 in total

1.  Injury characteristics and hemodynamics associated with guideline-compliant CPR in a pediatric porcine cardiac arrest model.

Authors:  David D Salcido; Allison C Koller; Cornelia Genbrugge; Ericka L Fink; Robert A Berg; James J Menegazzi
Journal:  Am J Emerg Med       Date:  2021-10-24       Impact factor: 2.469

Review 2.  Statistical methods for the analysis of adverse event data in randomised controlled trials: a scoping review and taxonomy.

Authors:  Rachel Phillips; Odile Sauzet; Victoria Cornelius
Journal:  BMC Med Res Methodol       Date:  2020-11-30       Impact factor: 4.615

3.  BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA®-Coded Adverse Events in Randomized Controlled Trials.

Authors:  Alma Revers; Michel H Hof; Aeilko H Zwinderman
Journal:  Drug Saf       Date:  2022-07-15       Impact factor: 5.228

4.  Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials.

Authors:  Junhao Liu; Jo Wick; Renee' H Martin; Caitlyn Meinzer; Dooti Roy; Byron Gajewski
Journal:  BMC Med Res Methodol       Date:  2020-08-17       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.